Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

A Pd-labile fluoroquinolone prodrug efficiently prevents biofilm formation on coated surfaces

  • Braun, Josef
  • Ortega Liébana, M. Carmen
  • Unciti-Broceta, Asier
  • Sieber, Stephan A.
Surface-adhered bacteria on implants represent a major challenge for antibiotic treatment. We introduce hydrogel-coated surfaces loaded with tailored Pd-nanosheets which catalyze the release of antibiotics from inactive prodrugs. Masked and antibiotically inactive fluoroquinolone analogs were efficiently activated at the surface and prevented the formation of Staphylococcus aureus biofilms., Doctoral fellowship of the Foundation of German Business, Merck Future Insight Prize 2020, EC (H2020-MSCA–IF–2018-841990), EPSRC (EP/S010289/1), EU H2020 (grant agreement no 823717 – ESTEEM3)
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

In Cellulo Bioorthogonal Catalysis by Encapsulated AuPd Nanoalloys: Overcoming Intracellular Deactivation

  • Rubio Ruiz, Belén|||0000-0003-4720-6578
  • Ortega Liébana, M. Carmen
  • Valero Griñán, María Teresa|||0000-0002-3625-311X
Bioorthogonal metallocatalysis has opened up a xenobiotic route to perform nonenzymatic catalytic transformations in living settings. Despite their promising features, most metals are deactivated inside cells by a myriad of reactive biomolecules, including biogenic thiols, thereby limiting the catalytic functioning of these abiotic reagents. Here we report the development of cytocompatible alloyed AuPd nanoparticles with the capacity to elicit bioorthogonal depropargylations with high efficiency in biological media. We also show that the intracellular catalytic performance of these nanoalloys is significantly enhanced by protecting them following two different encapsulation methods. Encapsulation in mesoporous silica nanorods resulted in augmented catalyst reactivity, whereas the use of a biodegradable PLGA matrix increased nanoalloy delivery across the cell membrane. The functional potential of encapsulated AuPd was demonstrated by releasing the potent chemotherapy drug paclitaxel inside cancer cells. Nanoalloy encapsulation provides a novel methodology to develop nanoreactors capable of mediating new-to-life reactions in cells., UK Research & Innovation (UKRI), Engineering & Physical Sciences Research Council (EPSRC) EP/N021134/1, ERC (Advanced Grant CADENCE) ERC-2016-ADG-742684, European Commission European Commission Joint Research Centre H2020-MSCA-IF-2014-658833 H2020-MSCA-IF-2018-841990 H2020-MSCA-IF-2016-749299 H2020-MSCA-IF-2019-895664, Spanish Government RTI2018-099019-A-I00
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dendritic platinum nanoparticles shielded by Pt-S PEGylation as intracellular reactors for bioorthogonal uncaging chemistry

  • García-Peiro, José I.
  • Ortega-Liébana, M. Carmen
  • Adam, Catherine
  • Lorente-Macías, Álvaro
  • Travnickova, Jana
  • Patton, E. Elizabeth
  • Guerrero-López, Paula
  • García-Aznar, José Manuel
  • Hueso, José L.
  • Santamaría, Jesús
  • Unciti-Broceta, Asier
Beyond their classical role as cytotoxics, Platinum (Pt) coordination complexes recently joined the selected group of transition metals capable of performing bioorthogonal reactions in living environments. To minimize their reactivity towards nucleophiles, which limit their catalytic performance, we investigated the use of Pt(0) with different forms, sizes and surface functionalization. We report herein the development of PEGylated Pt nanodendrites with the capacity to activate prodyes and prodrugs in cell culture and in vivo. Their dendritic morphology together with their surface shielding through Pt-S-bonded PEGylation synergistically contributed to create catalytic nanoreactors compatible with the highly-crowded and reductive environment of the cell cytoplasm, thereby facilitating in situ bioorthogonal drug uncaging in cancer cells in 2D and 3D culture, including in microfluidic systems, and xenografted in zebrafish., We are grateful to the EC (H2020-MSCA-IF-2018-841990) and EPSRC (EP/S010289/1) for financial support. We also would like to acknowledge the European Research Council (ERC) through the Catalytic Dual-Function Devices Against Cancer (CADENCE-742684) project, RLDI/2015-021. EEP is funded by the MRC (MC_UU_00035/13), Melanoma Research Alliance and Rosetrees Trust (MRA Awards 687306, 917226). This work was supported by the Cancer Research UK Scotland Centre (CTRQQR-2021\100006). MCOL is grateful to the Institute of Genetics and Cancer (IGC) for financial support through the Hastie Career Advancement Fund 2020, and the Consejeria de Universidad Investigacion e Innovacion by ERDF Andalusian Program 2021–2027 (A-EXP-278-UGR23). We thank IGC Zebrafish facility for supporting zebrafish management and IGC Imaging Facility for their support with imaging experiments. P.G.-L. gratefully acknowledges the support of the Government of Aragon (Grant No. 2021–25). The synthesis of materials has been performed by the Platform of Production of Biomaterials and Nanoparticles of the NANBIOSIS ICTS, more specifically by the Nanoparticle Synthesis Unit of the CIBER in BioEngineering, Biomaterials & Nanomedicine (CIBER-BBN). The TEM studies were conducted at the Laboratorio de Microscopias Avanzadas, Instituto de Nanociencia y Materiales de Aragon, Universidad de Zaragoza, Spain. (SAI and ELECMI). Ayuda CEX2023-001286-S financiada por MICIU/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Near-infrared light-accelerated bioorthogonal drug uncaging and photothermal ablation by anisotropic Pd@Au plasmonic nanorods

  • Ortega-Liébana, M. Carmen
  • Travnickova, Jana
  • Adam, Catherine
  • González-Calderón, Davir
  • Lorente-Macías, Álvaro
  • Lochenie, Charles
  • Arenal, Raúl
  • Patton, E. Elizabeth
  • Unciti-Broceta, Asier
Selective activation of chemotherapeutics at the tumor site via bioorthogonal catalysis is a promising strategy to reduce collateral damage to healthy tissues and organs. Despite significant advances in this field, targeted drug activation by transition-metal catalysts is still limited by insufficient spatiotemporal control over the metal-mediated uncaging process. Herein, we report the development of anisotropic Pd@Au plasmonic nanorods with the capacity to accelerate dealkylation reactions under near-infrared (NIR) irradiation, thereby enabling precise control over when and where these catalytic devices are switched on. We also show that the stability and in cellulo chemical properties of Pd@Au nanorods are enhanced by Au–S functionalization with PEGylated phospholipids and report the development of a novel masking group for prodyes and prodrugs: the POxOC group, designed to improve physicochemical properties and the rate of the Pd-triggered dye/drug release process. NIR-photoactivation of lipo-Pd@Au nanorods is able to catalyze the uncaging of inactive drug precursors and release heat to the environment, killing cancer cells in culture and xenografted in zebrafish. This work provides a novel targeted strategy for photothermal chemotherapy by NIR-laser focalization., We are grateful to the EC (H2020-MSCA–IF–2018–841990) and EPSRC (EP/S010289/1, EP/Y024540/1) for financial support. E.E.P. is funded by the MRC (MC_UU_00035/13), Melanoma Research Alliance, and Rosetrees Trust (MRA Awards 687306, 917226). This work was supported by the Cancer Research UK Scotland Centre (CTRQQR-2021\100006). M.C.O.L. is grateful to the Institute of Genetics and Cancer (IGC) for financial support through the Hastie Career Advancement Fund 2020 and to “La Caixa” Foundation (ID 100010434) for fellowship funding (142167) and to MCIN/AEI/10.13039/501100011033 for research funding (grant PID2023–147912OA-I00). (S)TEM characterization (FEI-Titan) was supported by EU H2020 (grant agreement no. 823717–ESTEEM3). R.A. acknowledges funding from the Spanish MICIU (PID2023–151080NB-I00/AEI/10.13039/501100011033 and CEX2023–001286-S MICIU/AEI/10.13039/501100011033) and by the DGA project E13–23R., Funding for open access charge: Universidad de Granada/CBUA., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Dendritic platinum nanoparticles shielded by Pt-S PEGylation as intracellular reactors for bioorthogonal uncaging Chemistry

  • García-Peiró, José I.
  • Ortega-Liébana, M. Carmen
  • Adam, Catherine
  • Lorente-Macías, Álvaro
  • Travnickova, Jana
  • Patton, E. Elizabeth
  • Guerrero-López, Paula
  • García-Aznar, J. Manuel
  • Hueso, José L.
  • Santamaría, Jesús
  • Unciti-Broceta, Asier
Beyond their classical role as cytotoxics, Platinum (Pt) coordination complexes recently joined the selected group of transition metals capable of performing bioorthogonal reactions in living environments. To minimize their reactivity towards nucleophiles, which limit their catalytic performance, we investigated the use of Pt(0) with different forms, sizes and surface functionalization. We report herein the development of PEGylated Pt nanodendrites with the capacity to activate prodyes and prodrugs in cell culture and in vivo. Their dendritic morphology together with their surface shielding through Pt‐S‐bonded PEGylation synergistically contributed to create catalytic nanoreactors compatible with the highly‐crowded and reductive environment of the cell cytoplasm, thereby facilitating in situ bioorthogonal drug uncaging in cancer cells in 2D and 3D culture, including in microfluidic systems, and xenografted in zebrafish.